MIT Schwarzman College of Computing
MIT Schwarzman College of Computing

How to assess a general-purpose AI model’s reliability before it’s deployed

A new technique enables users to compare several large models and choose the one that works best for their task.

Marking a milestone: Dedication ceremony celebrates the new MIT Schwarzman College of Computing building

Members of the MIT community, supporters, and guests commemorate the opening of the new college headquarters.

Reasoning skills of large language models are often overestimated

New CSAIL research highlights how LLMs excel in familiar scenarios but struggle in novel ones, questioning their true reasoning abilities versus reliance on memorization.

When to trust an AI model

More accurate uncertainty estimates could help users decide about how and when to use machine-learning models in the real world.

“They can see themselves shaping the world they live in”

Developed by MIT RAISE, the Day of AI curriculum empowers K-12 students to collaborate on local and global challenges using AI.

MIT researchers introduce generative AI for databases

This new tool offers an easier way for people to analyze complex tabular data.

Helping nonexperts build advanced generative AI models

MosaicML, co-founded by an MIT alumnus and a professor, made deep-learning models faster and more efficient. Its acquisition by Databricks broadened that mission.

MIT-Takeda Program wraps up with 16 publications, a patent, and nearly two dozen projects completed

The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.

Understanding the visual knowledge of language models

LLMs trained primarily on text can generate complex visual concepts through code with self-correction. Researchers used these illustrations to train an image-free computer vision system to recognize real photos.

A smarter way to streamline drug discovery

The SPARROW algorithm automatically identifies the best molecules to test as potential new medicines, given the vast number of factors affecting each choice.